Starbucks Coffee has opened a coffeehouse and drive-through in Greentree Plaza at 515 Everett Mall Way. The new outlet is 1,500 square feet and will employ 20 people. Its hours are 4:30 a.m.-11 p.m. Monday through Saturday and 5:30 a.m.-9 p.m. on Sunday.
Study may help attract new jobs
The Puget Sound Technology Corridor Partnership, the Economic Development Council of Snohomish County and three local consulting firms are cooperating on a study of economic and infrastructure requirements for several targeted industries. The study will identify the requirements to attract research and development and manufacturing work by companies in the biotechnology, biomedical devices, aerospace, business services and electronics industries. The goal is to let local cities know what projects might help attract jobs in these industries. The Technology Corridor Partnership includes the cities of Bothell, Lynnwood and Everett.
Epoch Biosciences narrows losses
Bothell’s Epoch Biosciences Inc., which makes research tools for the biotechnology industry, reported a second-quarter loss of $570,000, or 2 cents a share. Excluding a one-time gain from the adjusted value of stock warrants, the loss totaled $748,000, compared with a $3.1 million loss for the same period of 2003. Revenue decreased by 15 percent to $1.9 million. There was no income from contract research, compared with $392,000 for the same period last year.
Bothell biotech losses increase
Helix BioMedix Inc., a Bothell company specializing in wound-healing proteins called peptides, reported a net loss of $677,344, or 5 cents a share, during the second quarter. That compared with a loss of $617,463 during the same quarter of 2003. Second-quarter revenue totaled $45,300, compared to $39,100 a year ago. The company has $3.1 million in cash.
Nasdaq may dump Eden Bioscience
Eden Bioscience Corp. has received a letter from the Nasdaq Stock Market warning that the company’s stock could be dropped from the market’s listing if it doesn’t rise soon. The Bothell company, which makes a naturally based plant growth enhancer, has seen its share price mired below $1 a share since mid-June. It needs to rise above that level for at least 10 consecutive trading days before Jan. 26 in order to remain on the Nasdaq National Market. Tuesday’s news sent Eden’s stock further down, by 8 percent, to 46 cents a share.
From Herald staff reports
Talk to us
> Give us your news tips.
> Send us a letter to the editor.
> More Herald contact information.
